These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
512 related articles for article (PubMed ID: 28710377)
21. A simple method to induce hypoxia-induced vascular endothelial growth factor-A (VEGF-A) expression in T24 human bladder cancer cells. Cesário JM; Brito RB; Malta CS; Silva CS; Matos YS; Kunz TC; Urbano JJ; Oliveira LV; Dalboni MA; Dellê H In Vitro Cell Dev Biol Anim; 2017 Mar; 53(3):272-276. PubMed ID: 27752923 [TBL] [Abstract][Full Text] [Related]
22. Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis. Wang J; Li G; Wang Y; Tang S; Sun X; Feng X; Li Y; Bao G; Li P; Mao X; Wang M; Liu P Oncotarget; 2015 Dec; 6(42):44579-92. PubMed ID: 26625311 [TBL] [Abstract][Full Text] [Related]
23. Hovenia dulcis Thunb. and its active compound ampelopsin inhibit angiogenesis through suppression of VEGFR2 signaling and HIF-1α expression. Han JM; Lim HN; Jung HJ Oncol Rep; 2017 Dec; 38(6):3430-3438. PubMed ID: 29039561 [TBL] [Abstract][Full Text] [Related]
24. Hypoxia inducible factor-1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer. Zhu H; Zhang S J Cell Biochem; 2018 Sep; 119(9):7707-7718. PubMed ID: 29904944 [TBL] [Abstract][Full Text] [Related]
25. Adrenomedullin promotes angiogenesis in epithelial ovarian cancer through upregulating hypoxia-inducible factor-1α and vascular endothelial growth factor. Zhang Y; Xu Y; Ma J; Pang X; Dong M Sci Rep; 2017 Jan; 7():40524. PubMed ID: 28091613 [TBL] [Abstract][Full Text] [Related]
26. Liquiritigenin inhibits serum-induced HIF-1α and VEGF expression via the AKT/mTOR-p70S6K signalling pathway in HeLa cells. Xie SR; Wang Y; Liu CW; Luo K; Cai YQ Phytother Res; 2012 Aug; 26(8):1133-41. PubMed ID: 22170854 [TBL] [Abstract][Full Text] [Related]
27. Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder. Miyake M; Fujimoto K; Anai S; Ohnishi S; Kuwada M; Nakai Y; Inoue T; Matsumura Y; Tomioka A; Ikeda T; Tanaka N; Hirao Y Oncol Rep; 2011 Mar; 25(3):653-60. PubMed ID: 21206978 [TBL] [Abstract][Full Text] [Related]
28. Runx2 protein stabilizes hypoxia-inducible factor-1α through competition with von Hippel-Lindau protein (pVHL) and stimulates angiogenesis in growth plate hypertrophic chondrocytes. Lee SH; Che X; Jeong JH; Choi JY; Lee YJ; Lee YH; Bae SC; Lee YM J Biol Chem; 2012 Apr; 287(18):14760-71. PubMed ID: 22351759 [TBL] [Abstract][Full Text] [Related]
30. Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway. Lu N; Hui H; Yang H; Zhao K; Chen Y; You QD; Guo QL Eur J Pharm Sci; 2013 May; 49(2):220-6. PubMed ID: 23501055 [TBL] [Abstract][Full Text] [Related]
31. Aloe-emodin suppresses hypoxia-induced retinal angiogenesis Wu J; Ke X; Wang W; Zhang H; Ma N; Fu W; Zhao M; Gao X; Hao X; Zhang Z Int J Biol Sci; 2016; 12(11):1363-1371. PubMed ID: 27877088 [No Abstract] [Full Text] [Related]
32. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo. Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632 [TBL] [Abstract][Full Text] [Related]
33. Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha. Oh SH; Woo JK; Jin Q; Kang HJ; Jeong JW; Kim KW; Hong WK; Lee HY Int J Cancer; 2008 Jan; 122(1):5-14. PubMed ID: 17764071 [TBL] [Abstract][Full Text] [Related]
34. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment. De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519 [TBL] [Abstract][Full Text] [Related]
35. Suppression of VEGF expression through interruption of the HIF‑1α and Akt signaling cascade modulates the anti‑angiogenic activity of DAPK in ovarian carcinoma cells. Park ST; Kim BR; Park SH; Lee JH; Lee EJ; Lee SH; Rho SB Oncol Rep; 2014 Feb; 31(2):1021-9. PubMed ID: 24337450 [TBL] [Abstract][Full Text] [Related]
36. Minocycline accelerates hypoxia-inducible factor-1 alpha degradation and inhibits hypoxia-induced neovasculogenesis through prolyl hydroxylase, von Hippel-Lindau-dependent pathway. Li CH; Liao PL; Yang YT; Huang SH; Lin CH; Cheng YW; Kang JJ Arch Toxicol; 2014 Mar; 88(3):659-71. PubMed ID: 24292262 [TBL] [Abstract][Full Text] [Related]
37. Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1α mediated by the PTEN/PI3K/Akt pathway. Park JH; Lee JY; Shin DH; Jang KS; Kim HJ; Kong G Oncogene; 2011 Nov; 30(45):4578-89. PubMed ID: 21602890 [TBL] [Abstract][Full Text] [Related]
38. Pseudolaric acid B inhibits angiogenesis and reduces hypoxia-inducible factor 1alpha by promoting proteasome-mediated degradation. Li MH; Miao ZH; Tan WF; Yue JM; Zhang C; Lin LP; Zhang XW; Ding J Clin Cancer Res; 2004 Dec; 10(24):8266-74. PubMed ID: 15623602 [TBL] [Abstract][Full Text] [Related]
39. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells. Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818 [TBL] [Abstract][Full Text] [Related]
40. Cinnamic aldehyde suppresses hypoxia-induced angiogenesis via inhibition of hypoxia-inducible factor-1α expression during tumor progression. Bae WY; Choi JS; Kim JE; Jeong JW Biochem Pharmacol; 2015 Nov; 98(1):41-50. PubMed ID: 26297910 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]